Stromal Cell-Derived Factor-1α Activation of Tissue-Engineered Endothelial Progenitor Cell Matrix Enhances Ventricular Function After Myocardial Infarction by Inducing Neovasculogenesis

被引:75
作者
Frederick, John R. [1 ]
Fitzpatrick, J. Raymond, III [1 ]
McCormick, Ryan C. [1 ]
Harris, David A. [1 ]
Kim, Ah-Young [1 ]
Muenzer, Jeffrey R. [1 ]
Marotta, Nicole [1 ]
Smith, Maximilian J. [1 ]
Cohen, Jeffrey E. [1 ]
Hiesinger, William [1 ]
Atluri, Pavan [1 ]
Woo, Y. Joseph [1 ]
机构
[1] Univ Penn, Sch Med, Dept Surg, Div Cardiovasc Surg, Philadelphia, PA 19104 USA
关键词
angiogenesis; vasculogenesis; endothelial progenitor cells; extracellular matrix; ischemic heart disease; GROWTH-FACTOR; ISCHEMIC CARDIOMYOPATHY; CARDIAC-FUNCTION; TRANSPLANTATION; ANGIOGENESIS; THERAPY; NEOVASCULARIZATION; REVASCULARIZATION; PERFUSION;
D O I
10.1161/CIRCULATIONAHA.109.930404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Myocardial ischemia causes cardiomyocyte death, adverse ventricular remodeling, and ventricular dysfunction. Endothelial progenitor cells (EPCs) have been shown to ameliorate this process, particularly when activated with stromal cell-derived factor-1 alpha (SDF), known to be the most potent EPC chemokine. We hypothesized that implantation of a tissue-engineered extracellular matrix (ECM) scaffold seeded with EPCs primed with SDF could induce borderzone neovasculogenesis, prevent adverse geometric remodeling, and preserve ventricular function after myocardial infarction. Methods and Results-Lewis rats (n=82) underwent left anterior descending artery ligation to induce myocardial infarction. EPCs were isolated, characterized, and cultured on a vitronectin/collagen scaffold and primed with SDF to generate the activated EPC matrix (EPCM). EPCM was sutured to the anterolateral left ventricular wall, which included the region of ischemia. Control animals received sutures but no EPCM. Additional groups underwent application of the ECM alone, ECM primed with SDF (ECM+SDF), and ECM seeded with EPCs but not primed with SDF (ECM+SDF). At 4 weeks, borderzone myocardial tissue demonstrated increased levels of vascular endothelial growth factor in the EPCM group. When compared to controls, Vessel density as assessed by immunohistochemical microscopy was significantly increased in the EPCM group (4.1 versus 6.2 vessels/high-powered field; P<0.001), and microvascular perfusion measured by lectin microangiography was enhanced 4-fold (0.7% versus 2.7% vessel volume/section volume; P=0.04). Comparisons to additional groups also showed a significantly improved vasculogenic response in the EPCM group. Ventricular geometry and scar fraction assessed by digital planimetric analysis of sectioned hearts exhibited significantly preserved left ventricular internal diameter (9.7 mm versus 8.6 mm; P=0.005) and decreased infarct scar formation expressed as percent of total section area (16% versus 7%; P=0.002) when compared with all other groups. In addition, EPCM animals showed a significant preservation of function as measured by echocardiography, pressure-volume conductance, and Doppler flow. Conclusions-Extracellular matrix seeded with EPCs primed with SDF induces borderzone neovasculogenesis, attenuates adverse ventricular remodeling, and preserves ventricular function after myocardial infarction. (Circulation. 2010; 122[suppl 1]:S107-S117.)
引用
收藏
页码:S107 / S117
页数:11
相关论文
共 25 条
  • [11] Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
    Kocher, AA
    Schuster, MD
    Szabolcs, MJ
    Takuma, S
    Burkhoff, D
    Wang, J
    Homma, S
    Edwards, NM
    Itescu, S
    [J]. NATURE MEDICINE, 2001, 7 (04) : 430 - 436
  • [12] Chronic heart failure induced by coronary artery ligation in Lewis inbred rats
    Liu, YH
    Yang, XP
    Nass, O
    Sabbah, HN
    Peterson, E
    Carretero, OA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (02): : H722 - H727
  • [13] Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina -: A phase I/IIa double-blind, randomized controlled trial
    Losordo, Douglas W.
    Schatz, Richard A.
    White, Christopher J.
    Udelson, James E.
    Veereshwarayya, Vimal
    Durgin, Michelle
    Poh, Kian Keong
    Weinstein, Robert
    Kearney, Marianne
    Chaudhry, Muqtada
    Burg, Aaron
    Eaton, Liz
    Heyd, Lindsay
    Thorne, Tina
    Shturman, Leon
    Hoffmeister, Peter
    Story, Ken
    Zak, Victor
    Dowling, Douglas
    Traverse, Jay H.
    Olson, Rachel E.
    Flanagan, Janice
    Sodano, Donata
    Murayama, Toshinori
    Kawamoto, Atsuhiko
    Kusano, Kengo Fukushima
    Wollins, Jill
    Welt, Frederick
    Shah, Pinak
    Soukas, Peter
    Asahara, Takayuki
    Henry, Timothy D.
    [J]. CIRCULATION, 2007, 115 (25) : 3165 - 3172
  • [14] Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells
    Murasawa, S
    Llevadot, J
    Silver, M
    Isner, JM
    Losordo, DW
    Asahara, T
    [J]. CIRCULATION, 2002, 106 (09) : 1133 - 1139
  • [15] Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats
    Pacher, Pal
    Nagayama, Takahiro
    Mukhopadhyay, Partha
    Batkai, Sandor
    Kass, David A.
    [J]. NATURE PROTOCOLS, 2008, 3 (09) : 1422 - 1434
  • [16] Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts
    Sekine, Hidekazu
    Shimizu, Tatsuya
    Hobo, Kyoko
    Sekiya, Sachiko
    Yang, Joseph
    Yamato, Masayuki
    Kurosawa, Hiromi
    Kobayashi, Eiji
    Okano, Teruo
    [J]. CIRCULATION, 2008, 118 (14) : S145 - S152
  • [17] Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia
    Sellke, FW
    Li, JY
    Stamler, A
    Lopez, JJ
    Thomas, KA
    Simons, M
    [J]. SURGERY, 1996, 120 (02) : 182 - 188
  • [18] Safety and efficacy of peripheral blood progenitor cell mobilization and collection in patients with advanced coronary heart disease
    Sinha, Sudha
    Poh, Kian-Keong
    Sodano, Donata
    Flanagan, Janice
    Ouilette, Cindy
    Kearney, Marianne
    Heyd, Lindsay
    Wollns, Jill
    Losordo, Douglas
    Weinstein, Robert
    [J]. JOURNAL OF CLINICAL APHERESIS, 2006, 21 (02) : 116 - 120
  • [19] THERAPEUTIC ANGIOGENESIS - A SINGLE INTRAARTERIAL BOLUS OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AUGMENTS REVASCULARIZATION IN A RABBIT ISCHEMIC HIND-LIMB MODEL
    TAKESHITA, S
    ZHENG, LP
    BROGI, E
    KEARNEY, M
    PU, LQ
    BUNTING, S
    FERRARA, N
    SYMES, JF
    ISNER, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) : 662 - 670
  • [20] Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells
    Urbich, C
    Aicher, A
    Heeschen, C
    Dernbach, E
    Hofmann, WK
    Zeiher, AM
    Dimmeler, S
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 39 (05) : 733 - 742